Home > Qtrly Results > GLAND PHARMA

GLAND PHARMA
Quarterly Results Analysis [Dec2023]

GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Quarterly Results

Consolidated Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
Audited
Jun2022
UnAudited
Mar2022
Audited
Revenues ₹1,545 Cr ₹1,373 Cr ₹1,209 Cr ₹785 Cr ₹938 Cr ₹1,044 Cr ₹857 Cr ₹1,103 Cr
Expenses ₹1,189 Cr ₹1,049 Cr ₹915 Cr ₹617 Cr ₹649 Cr ₹748 Cr ₹587 Cr ₹755 Cr
Operating Income ₹356 Cr ₹324 Cr ₹294 Cr ₹168 Cr ₹290 Cr ₹297 Cr ₹270 Cr ₹348 Cr
Other Income ₹37 Cr ₹53 Cr ₹38 Cr ₹39 Cr ₹62 Cr ₹66 Cr ₹74 Cr ₹65 Cr
Interest ₹5 Cr ₹6 Cr ₹5 Cr ₹2 Cr ₹3 Cr ₹2 Cr ₹1 Cr ₹2 Cr
Depreciation ₹105 Cr ₹81 Cr ₹65 Cr ₹38 Cr ₹38 Cr ₹37 Cr ₹35 Cr ₹31 Cr
Profit Before Tax ₹283 Cr ₹290 Cr ₹261 Cr ₹111 Cr ₹311 Cr ₹324 Cr ₹308 Cr ₹380 Cr
Profit After Tax ₹192 Cr ₹194 Cr ₹194 Cr ₹79 Cr ₹232 Cr ₹241 Cr ₹229 Cr ₹286 Cr
EPS ₹11.65 ₹11.78 ₹11.79 ₹4.78 ₹14.08 ₹14.65 ₹13.92 ₹17.40
Industry Peers & Returns1W1M1Y
GLAND PHARMA -2.7% -3.7% 32.7%
SUN PHARMACEUTICAL INDUSTRIES -2.3% -6.5% 55.3%
CIPLA 4.1% -4.8% 55.6%
DR REDDYS LABORATORIES 4% 0.8% 29.4%
ZYDUS LIFESCIENCES -1.2% -5.2% 83.9%
DIVIS LABORATORIES 7.8% 17.4% 20.3%
MANKIND PHARMA 1.3% 7% NA
TORRENT PHARMACEUTICALS 3.9% 5.1% 66.1%
LUPIN 0.6% 0.5% 127.2%

GLAND PHARMA Quarterly Revenues

Revenues
Q-o-Q

12.50 %

Y-o-Y

64.68 %

Quarters Revenues % Change
Dec2023 ₹1,545 Cr
12.50
Sep2023 ₹1,373 Cr
13.63
Jun2023 ₹1,209 Cr
53.97
Mar2023 ₹785 Cr
-16.34
Dec2022 ₹938 Cr
-10.16
Sep2022 ₹1,044 Cr
21.88
Jun2022 ₹857 Cr
-22.31
Mar2022 ₹1,103 Cr -

GLAND PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

9.97 %

Y-o-Y

23.07 %

Quarters Operating Profit % Change
Dec2023 ₹356 Cr
9.97
Sep2023 ₹324 Cr
10.25
Jun2023 ₹294 Cr
74.54
Mar2023 ₹168 Cr
-41.84
Dec2022 ₹290 Cr
-2.45
Sep2022 ₹297 Cr
9.98
Jun2022 ₹270 Cr
-22.52
Mar2022 ₹348 Cr -
Operating Margins
Q-o-Q

-2.29 %

Y-o-Y

-25.28 %

Quarters Operating Margin% % Change
Dec2023 23.06%
-2.29
Sep2023 23.6%
-2.96
Jun2023 24.32%
13.38
Mar2023 21.45%
-30.49
Dec2022 30.86%
8.59
Sep2022 28.42%
-9.78
Jun2022 31.5%
-0.25
Mar2022 31.58% -

GLAND PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-1.15 %

Y-o-Y

-17.29 %

Quarters Profit After Tax % Change
Dec2023 ₹192 Cr
-1.15
Sep2023 ₹194 Cr
-0.01
Jun2023 ₹194 Cr
146.69
Mar2023 ₹79 Cr
-66.08
Dec2022 ₹232 Cr
-3.85
Sep2022 ₹241 Cr
5.27
Jun2022 ₹229 Cr
-19.84
Mar2022 ₹286 Cr -
PAT Margins
Q-o-Q

-12.10 %

Y-o-Y

-49.76 %

Quarters PAT Margin(%) % Change
Dec2023 12.42 %
-12.10
Sep2023 14.13 %
-12.02
Jun2023 16.06 %
60.28
Mar2023 10.02 %
-59.47
Dec2022 24.72 %
7.01
Sep2022 23.1 %
-13.61
Jun2022 26.74 %
3.16
Mar2022 25.92 % -

GLAND PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-1.10 %

Y-o-Y

-17.26 %

Quarters EPS % Change
Dec2023 ₹11.65
-1.10
Sep2023 ₹11.78
-0.08
Jun2023 ₹11.79
146.65
Mar2023 ₹4.78
-66.05
Dec2022 ₹14.08
-3.89
Sep2022 ₹14.65
5.24
Jun2022 ₹13.92
-20.00
Mar2022 ₹17.4 -

You may also like the below Video Courses